Clinical Trial: Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
Study Status: Completed
Recruit Status: RECRUITING
Condition: SARS-CoV-2 Infection
Study Type: INTERVENTIONAL
Official Title: A Phase I Study of the Safety and Immunogenicity of the Recombinant, Live-Attenuated, Bovine/Human Parainfluenza Virus Vector Vaccine Expressing the 6P-Prefusion-Stabilized Version of the SARS-Co
Brief Summary:
This Phase 1 clinical trial will evaluate the safety and immunogenicity of an intranasal vaccine candidate, a recombinant, live-attenuated, bovine/human parainfluenza virus vector vaccine expressing the 6-P prefusion-stabilized version of the SARS-CoV-2 spike protein.
Read more